Evoke Pharma Inc

NASDAQ:EVOK   10:00:52 AM EDT
1.34
-0.03 (-2.19%)
Earnings Announcements

Evoke Pharma Reports Second Quarter 2021 Financial Results

Published: 08/12/2021 22:05 GMT
Evoke Pharma Inc (EVOK) - Evoke Pharma Reports Second Quarter 2021 Financial Results.
Evoke Pharma Inc - Net Loss for Q2 of 2021 Was Approximately $2.3 Million, Or $0.07 per Share.
Revenue is expected to be $0.38 Million
Adjusted EPS is expected to be -$0.07

Next Quarter Revenue Guidance is expected to be $0.57 Million
Next Quarter EPS Guidance is expected to be -$0.07

More details on our Analysts Page.